For Patients and Families

For Healthcare Professionals

Are you a healthcare professional?

Go back

09.05.2020

Resources from the KCNQ2 Cure Alliance

What is KCNQ2 Epilepsy? – KCNQ2 Cure Alliance

what does kcnq2 stand for

Keep reading

Knopp Biosciences Presents New Phase 2 Data at ERS 2021 Demonstrating that Reduction in Eosinophil Count by Dexpramipexole Significantly Correlates with Improvement in Lung Function

Discover this News

Knopp Biosciences Reports Positive Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma at ATS 2021

Discover this News

Knopp Biosciences to Present Details of Positive Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma at ATS 2021

Discover this News

Crafting a Cure for Diabetic Neuropathic Pain, Molecule by Molecule (Published by NIH)

Discover this News

Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma

Discover this News

Knopp Disclaimer

Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.